FAM134B was originally identified as an oncogene found in esophageal squamous cell carcinoma, and dysfunction of FAM134B results in viral infection, inflammation, hereditary sensory and autonomic neuropathy type II, and cancer (6, 7, 8, 9, 10). This evidence concerns the gene RETREG1 and hereditary sensory and autonomic neuropathy type 2.